Hans-Christian Slotved1, Tine Dalby2, Steen Hoffmann2. 1. Neisseria and Streptococcus Reference Laboratory, Department of Microbiology and Infection Control, Statens Serum Institut, Copenhagen, Denmark. Electronic address: hcs@ssi.dk. 2. Neisseria and Streptococcus Reference Laboratory, Department of Microbiology and Infection Control, Statens Serum Institut, Copenhagen, Denmark.
Abstract
BACKGROUND: Surveillance data on invasive pneumococcal disease (IPD) in Denmark (1999-2014) was analysed regarding the incidence and age-distribution due to ten selected non-PCV serotypes (10-Non-PCV). The effect of PCV-7 and PCV-13 vaccines on the 10-Non-PCV IPD incidence was examined. METHODS: IPD cases caused by serotypes included in PCV-7, the additional six serotypes included in PCV-13 and 10-Non-PCV serotypes were identified (8, 9N, 11A, 12F, 15A, 22F, 24F, 20, 23B, 33F). The IPD incidence was stratified by three age groups: 0-4 years, 5-64 years and 65+ years. RESULTS: The predominant IPD cases were caused by serotypes that are not included in PCV-13 (71%), followed by the six additional PCV-13 serotypes. The IPD incidence of serotypes included in the PCV-7 decreased markedly after PCV-7 introduction but are still diagnosed at a low level. The IPD incidence for the 10-Non-PCV serotypes was low for age groups 0-4 years and 5-64 years but high for 65+ years. CONCLUSION: Future vaccinations of the young age group alone with a vaccine targeting some of the 10-Non-PCV serotypes may not elicit the desired effect on herd protection since these serotypes are primarily causing IPD among the elderly. Future pneumococcal vaccination strategies in Denmark may therefore need carriage studies in order to identify among whom the pneumococcal serotypes causing IPD are carried.
BACKGROUND: Surveillance data on invasive pneumococcal disease (IPD) in Denmark (1999-2014) was analysed regarding the incidence and age-distribution due to ten selected non-PCV serotypes (10-Non-PCV). The effect of PCV-7 and PCV-13 vaccines on the 10-Non-PCV IPD incidence was examined. METHODS: IPD cases caused by serotypes included in PCV-7, the additional six serotypes included in PCV-13 and 10-Non-PCV serotypes were identified (8, 9N, 11A, 12F, 15A, 22F, 24F, 20, 23B, 33F). The IPD incidence was stratified by three age groups: 0-4 years, 5-64 years and 65+ years. RESULTS: The predominant IPD cases were caused by serotypes that are not included in PCV-13 (71%), followed by the six additional PCV-13 serotypes. The IPD incidence of serotypes included in the PCV-7 decreased markedly after PCV-7 introduction but are still diagnosed at a low level. The IPD incidence for the 10-Non-PCV serotypes was low for age groups 0-4 years and 5-64 years but high for 65+ years. CONCLUSION: Future vaccinations of the young age group alone with a vaccine targeting some of the 10-Non-PCV serotypes may not elicit the desired effect on herd protection since these serotypes are primarily causing IPD among the elderly. Future pneumococcal vaccination strategies in Denmark may therefore need carriage studies in order to identify among whom the pneumococcal serotypes causing IPD are carried.
Authors: Michelle McFarland; Taylor P Szasz; Julie Y Zhou; Kara Motley; Janardan S Sivapalan; Megan Isaacson-Schmid; Elizabeth M Todd; Patrick G Hogan; Stephanie A Fritz; Carey-Ann D Burnham; Steen Hoffmann; Sharon Celeste Morley Journal: Vaccine Date: 2017-07-04 Impact factor: 3.641
Authors: Feroze Ganaie; Karsten Maruhn; Chengxin Li; Richard J Porambo; Pernille L Elverdal; Chitrananda Abeygunwardana; Mark van der Linden; Jens Ø Duus; Carmen L Sheppard; Moon H Nahm Journal: J Clin Microbiol Date: 2021-06-18 Impact factor: 5.948
Authors: Melina Messaoudi; Milen Milenkov; Werner C Albrich; Mark P G van der Linden; Thomas Bénet; Monidarin Chou; Mariam Sylla; Patricia Barreto Costa; Nathalie Richard; Keith P Klugman; Hubert P Endtz; Gláucia Paranhos-Baccalà; Jean-Noël Telles Journal: PLoS One Date: 2016-03-17 Impact factor: 3.240
Authors: Eric S Donkor; Jennifer A Annan; Ebenezer V Badoe; Nicholas T K D Dayie; Appiah-Korang Labi; Hans-Christian Slotved Journal: BMC Infect Dis Date: 2017-02-08 Impact factor: 3.090
Authors: Hans-Christian Slotved; Carmen L Sheppard; Tine Dalby; Arie van der Ende; Norman K Fry; Eva Morfeldt; Outi Nyholm; Assaf Rokney; Merav Ron; Lotta Siira; Kevin J Scott; Andrew Smith; Louise Thom; Maija Toropainen; Didrik F Vestrheim Journal: Sci Rep Date: 2017-10-16 Impact factor: 4.379